What does the PET scan show?
FDG provides a signal the the PET scanner detects–tissues that are under-using or over-using glucose. Cancer cells, because they are dividing faster than normal cells, use more glucose than normal tissures. The PET Scanner is able to demonstrate the distribution of the FDG in the body. The FDA has indicated FDG in positron emission tomography (PET) imaging: to assist in the evaluation o fmalignancy in patients with known or suspected abnormalities found by other tests, or in patients with existing diagnosis of cancer. Important information to know about referring a patient: The basic principle behind PET scanning requires that information about the general health and status of the patient be gathered. Diseases, infections, or surgeries can affect the use of glucose in tissues, so it is importnat that the staff at SWFL Regional Imaging has access to patient information, such as progress notes and a recent history and physical and any previous imaging studies (like CT, MR or Xrays) for
